Literature DB >> 28000583

Clinical characteristics and outcomes of tuberculosis in Douala, Cameroon: a 7-year retrospective cohort study.

B H Mbatchou Ngahane1, F Dahirou2, C Tchieche3, A Wandji3, C Ngnié3, A Nana-Metchedjin3, E Nyankiyé3, M L Endale Mangamba3, C Kuaban4.   

Abstract

SETTING: Tuberculosis (TB) clinic, Douala Laquintinie Hospital, Douala, Cameroon.
OBJECTIVE: To describe the clinical characteristics of TB and to investigate predictors of poor treatment outcomes.
DESIGN: A registry-based, retrospective cohort study of all TB cases recorded from 2007 to 2013 was conducted. Multinomial logistic regression models were used to identify predictors of poor outcomes.
RESULTS: Of 8902 TB cases included, 5110 (57.4%) were males. The median age was 33 years. The prevalence of human immunodeficiency virus (HIV) infection was 37.6%, with a significant decline over the study years (P = 0.000). The main clinical form of TB was smear-positive TB (50.5%). The treatment success rate was 75.2%, while the mortality rate was 8.1%. The year of TB diagnosis, retreatment cases, sputum non-conversion at the end of month 2, HIV infection and HIV testing not done were associated with death. Retreatment and non-conversion of sputum were associated with treatment failure, while male sex, age, sputum non-conversion, HIV infection and HIV testing not done were associated with loss to follow-up.
CONCLUSION: TB management objectives may be attained by focusing specifically on higher risk groups to prevent poor treatment outcomes.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 28000583     DOI: 10.5588/ijtld.15.0731

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  7 in total

1.  Clinical significance of Glasgow Prognostic Score in patients with tuberculous pleurisy.

Authors:  Hye Seon Kang; Hwa Young Lee; Jung Im Jung; Ju Sang Kim; Yong Hyun Kim; Seung Joon Kim; Seok Chan Kim; Soon Seog Kwon; Young Kyoon Kim; Ji Young Kang
Journal:  J Thorac Dis       Date:  2018-11       Impact factor: 2.895

2.  Factors associated with unfavourable tuberculosis treatment outcomes in Lusaka, Zambia, 2015: a secondary analysis of routine surveillance data.

Authors:  Francis Hamaimbo Nanzaluka; Sylvia Chibuye; Clara Chola Kasapo; Nelia Langa; Sulani Nyimbili; Given Moonga; Nathan Kapata; Ramya Kumar; Gershom Chongwe
Journal:  Pan Afr Med J       Date:  2019-04-08

3.  Predictors of tuberculosis treatment outcomes among a retrospective cohort in rural, Central India.

Authors:  Timothy S Laux; Sushil Patil
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2018-07-03

4.  Directly observed therapy and risk of unfavourable tuberculosis treatment outcomes among an international cohort of people living with HIV in low- and middle-income countries.

Authors:  April C Pettit; Cathy A Jenkins; Meridith Blevins Peratikos; Marcel Yotebieng; Lameck Diero; Cuong D Do; Jeremy Ross; Valdilea G Veloso; Denise Hawerlander; Olivier Marcy; Bryan E Shepherd; Lukas Fenner; Timothy R Sterling
Journal:  J Int AIDS Soc       Date:  2019-12       Impact factor: 5.396

Review 5.  Tuberculosis Treatment Outcome and Predictors in Africa: A Systematic Review and Meta-Analysis.

Authors:  Melese Yeshambaw Teferi; Ziad El-Khatib; Minyahil Tadesse Boltena; Azeb Tarekegn Andualem; Benedict Oppong Asamoah; Mulatu Biru; Hawult Taye Adane
Journal:  Int J Environ Res Public Health       Date:  2021-10-12       Impact factor: 4.614

6.  Factors predictive of the success of tuberculosis treatment: A systematic review with meta-analysis.

Authors:  Ninfa Marlen Chaves Torres; Jecxy Julieth Quijano Rodríguez; Pablo Sebastián Porras Andrade; María Belen Arriaga; Eduardo Martins Netto
Journal:  PLoS One       Date:  2019-12-27       Impact factor: 3.240

7.  Risk Factor for Retreatment Episode on Admission Among TB Patients With Schizophrenia.

Authors:  Hai-Rong Wang; Chao Han; Jun-Li Wang; Yan-An Zhang; Mao-Shui Wang
Journal:  Front Psychiatry       Date:  2021-12-09       Impact factor: 4.157

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.